Welcome to our dedicated page for WisdomTree SEC filings (Ticker: WT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
WisdomTree, Inc. filings document the regulatory record of a NYSE-listed asset manager whose common stock trades under the symbol WT. The company's Form 8-K disclosures cover quarterly operating and financial results, material events, material agreements, capital-structure matters and securities registered under the Exchange Act.
WisdomTree's filings also include proxy materials addressing governance, named executive officer compensation and shareholder voting matters. Capital-structure disclosures include senior unsecured convertible notes and related agreements, while recurring reporting categories connect the company's ETP advisory business, digital fund initiatives, governance practices and financing activity.
Naidoo Shamla reported acquisition or exercise transactions in this Form 4 filing.
WisdomTree, Inc. director Shamla Naidoo received a grant of 5,509 shares of Common Stock as a restricted stock award, recorded at no cash cost per share. These 5,509 restricted shares are scheduled to vest on June 17, 2027, and her direct holdings after the award total 40,194 shares. This is a compensation-related equity grant rather than an open-market purchase.
WisdomTree, Inc. director Daniela Mielke received 5,509 restricted stock units (RSUs) of common stock as a compensation award, at no cash cost. The RSUs vest on June 17, 2027 and will convert one-for-one into common shares upon the earliest of January 1, 2029, a qualifying separation from service, or a qualifying Sale Event. Following this grant, she directly holds 56,833 shares of common stock.
WisdomTree, Inc. director Rilla S. Delorier reported an equity compensation grant of common stock. She received a restricted stock award covering 5,509 shares of common stock at no cash cost, which is scheduled to vest on June 17, 2027.
Following this award, Delorier directly holds 37,360 shares of WisdomTree common stock. This Form 4 reflects a compensation-related acquisition rather than an open-market purchase or sale.
WisdomTree, Inc. director Smita Conjeevaram received a grant of 5,509 restricted stock units (RSUs) of common stock under the company’s 2022 Equity Plan and Non-Employee Directors' Deferred Compensation Program. These RSUs vest on June 17, 2027 and convert one-for-one into common shares. Following this award, she directly holds 82,877 shares of WisdomTree common stock.
Bossone Anthony reported acquisition or exercise transactions in this Form 4 filing.
WisdomTree, Inc. director Anthony Bossone received an equity grant of 5,509 restricted stock units (RSUs) of Common Stock. The RSUs were granted at no cash cost to him as director compensation and increase his direct holdings to 650,898 shares. The common stock underlying these RSUs will vest on June 17, 2027, and is payable on a one-for-one basis upon the earlier of a qualifying separation from service or a defined Sale Event under the company’s 2022 Equity Plan, consistent with Section 409A rules.
WisdomTree, Inc. reported that director Lynn S. Blake received an equity award in the form of 5,509 shares of common stock, granted at no cash cost as part of the non-employee directors’ compensation program under the 2022 Equity Plan.
The award is structured as restricted stock units that vest on June 17, 2027 under Blake’s deferral election and convert into common stock on a one-for-one basis. Shares become payable upon the earlier of a separation from service or a qualifying Sale Event as defined under the plan and Section 409A rules.
Following this grant, Blake directly holds 62,571 shares of WisdomTree common stock, reflecting a routine compensation-related increase in her equity stake rather than an open-market purchase.
WisdomTree, Inc. entered into privately negotiated agreements to repurchase approximately $51.9 million in aggregate principal amount of its 3.25% Convertible Senior Notes due 2029 for a total cash price of about $87.3 million. These note repurchase transactions are expected to close on June 1, 2026, subject to customary closing conditions.
After the transactions are completed, roughly $18.1 million of these convertible notes will remain outstanding. The company highlights that statements about the expected closing are forward-looking and could differ from current expectations due to various risks described in its prior SEC reports.
WisdomTree, Inc. President and COO Jarrett R. Lilien reported an open-market sale of 30,000 shares of Common Stock at $18.99 per share on May 20, 2026, executed under a pre-established Rule 10b5-1 trading plan.
After this sale, he directly holds 1,110,245 shares, including restricted stock awards scheduled to vest in tranches on January 25, 2027, January 25, 2028, and January 25, 2029, and his sales remain subject to the company’s equity ownership requirements.
WisdomTree, Inc. Chief Administrative Officer Peter M. Ziemba sold 100,000 shares of common stock in an open-market transaction on May 19, 2026 at a weighted average price of $19.31 per share, with individual sale prices ranging from $19.25 to $19.34.
After this sale, he holds 885,686 shares directly. This total includes restricted stock awards scheduled to vest as to 44,646 shares on January 25, 2027, 22,733 shares on January 25, 2028, and 8,619 shares on January 25, 2029.
Issuer files a Form 144 reporting a proposed sale of 30,000 shares. The notice lists a proposed sale on 02/25/2026 of 30,000 shares for $505,200 by an affiliate at a broker address in Smithfield, RI. The filing also lists prior restricted stock vesting entries dated 12/11/2018, 01/25/2019, and 10/29/2019 with listed share amounts.